Liquidia (LQDA) Common Equity (2019 - 2026)
Liquidia's (LQDA) quarterly Common Equity came in at $108.6 million in Q1 2026, up 118.41% year-on-year from $49.7 million in Q1 2025, and up 142.65% quarter-over-quarter from $44.7 million in Q4 2025.
Liquidia (LQDA) Common Equity (2019 - 2026) Analysis & Trends
Liquidia's Common Equity history runs 8 years deep, the most recent figure standing at $108.6 million for Q1 2026.
- On a quarterly basis, Common Equity rose 118.41% year-over-year to $108.6 million in Q1 2026; TTM through Mar 2026 was $108.6 million, a 118.41% increase from a year earlier, with the FY2025 full-year figure at $44.7 million, down 43.63% from the prior year.
- Common Equity grew to $108.6 million in Q1 2026 per LQDA's latest filing, from $44.7 million in the prior quarter.
- Across five years, Common Equity topped out at $112.8 million in Q3 2024 and bottomed at $15.2 million in Q2 2025.
- The 5-year median for Common Equity is $72.8 million (2024), against an average of $69.6 million.
- Across the five-year window, Common Equity jumped 134.89% in 2024 and slumped 80.44% in 2025, its largest moves.
- Year by year, Common Equity stood at $90.4 million in 2022, then tumbled by 47.7% to $47.3 million in 2023, then jumped by 67.84% to $79.4 million in 2024, then slumped by 43.63% to $44.7 million in 2025, then jumped by 142.65% to $108.6 million in 2026.
- Per Business Quant, the three latest LQDA Common Equity figures stand at $108.6 million (Q1 2026), $44.7 million (Q4 2025), and $22.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 108.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108.58 Mn |
| Dec 31, 2025 | 44.75 Mn |
| Sep 30, 2025 | 22.05 Mn |
| Jun 30, 2025 | 15.19 Mn |
| Mar 31, 2025 | 49.71 Mn |
| Dec 31, 2024 | 79.38 Mn |
| Sep 30, 2024 | 112.76 Mn |
| Jun 30, 2024 | 72.84 Mn |
| Mar 31, 2024 | 97.11 Mn |
| Dec 31, 2023 | 47.29 Mn |
| Sep 30, 2023 | 48.01 Mn |
| Jun 30, 2023 | 60.66 Mn |
| Mar 31, 2023 | 81.64 Mn |
| Dec 31, 2022 | 90.42 Mn |
| Sep 30, 2022 | 95.03 Mn |
| Jun 30, 2022 | 102.11 Mn |
| Mar 31, 2022 | 55.39 Mn |
| Dec 31, 2021 | 65.27 Mn |
| Sep 30, 2021 | 72.96 Mn |
| Jun 30, 2021 | 79.02 Mn |